8-K: Tilray Brands Reports Strong Q3 Revenue Growth, Driven by Beverage and Cannabis Segments

Tilray Brands saw a 30% increase in net revenue in the third quarter of fiscal year 2024, fueled by significant growth in its beverage-alcohol and cannabis divisions.

Summary

• Tilray Brands reported a net revenue of $188.3 million for the third quarter of fiscal year 2024, a 30% increase compared to the same period last year.
• The company's beverage-alcohol net revenue surged by 165% to $54.7 million, while global cannabis net revenue increased by 33% to $63.4 million.
• Gross profit was $49.4 million, with an adjusted gross profit of $51.6 million, representing a 17% increase.
• The company's net loss decreased significantly to $105 million, compared to a net loss of $1.2 billion in the prior year quarter.
• Adjusted EBITDA was $10.2 million, compared to $13.3 million in the prior year quarter.
• Tilray has a strong financial liquidity position with approximately $226 million, including $146.3 million in cash and $79.6 million in marketable securities.
• The company reduced its outstanding convertible debt by $50.7 million during the quarter and a further $41.9 million after the quarter end.
• Tilray is now guiding to an Adjusted EBITDA target of $60 million to $63 million for the fiscal year ending May 31, 2024, but no longer expects to generate positive adjusted free cash flow for the full fiscal year due to delayed cash collection on asset sales.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with strong revenue growth but some concerns about profitability and cash flow. The debt reduction and strategic acquisitions are positive, but the lower EBITDA and negative free cash flow guidance temper the overall sentiment.

Positives

• Tilray experienced substantial revenue growth across its core business segments.
• The company successfully reduced its convertible debt balance.
• Tilray is progressing with the integration of recently acquired craft beverage brands.
• Operating synergies are being realized from the HEXO acquisition.
• The company completed its Canadian and international cannabis cost reduction plans.
• Tilray has a strong financial liquidity position.
• The company is the #1 Canadian cannabis LP and the European market leader in medical cannabis.
• Tilray has increased its market share of total beer in 13 states since the Craft Acquisition.

Negatives

• Adjusted EBITDA decreased to $10.2 million from $13.3 million in the prior year quarter.
• Beverage-alcohol gross margin decreased from 48% to 34% due to the acquisition of craft brands with lower margins.
• Cannabis adjusted gross margin decreased from 47% to 33% due to the termination of the HEXO advisory services agreement and a change in sales mix.
• Distribution revenue was impacted by regulatory changes, IT outages, and weather.
• The company no longer expects to generate positive adjusted free cash flow for the full fiscal year 2024 due to delayed cash collection on asset sales.

Risks

• The company faces challenges in integrating acquired craft brands and optimizing brewery utilization.
• Regulatory changes and IT infrastructure issues can negatively impact distribution revenue.
• The company's profitability is affected by lower margins in acquired craft brands and changes in cannabis sales mix.
• The delay in collecting cash on asset sales impacts the company's free cash flow.
• The company's future performance is subject to the risks and uncertainties associated with the cannabis and beverage industries.

Future Outlook

Tilray is now guiding to an Adjusted EBITDA target of $60 million to $63 million for the fiscal year ending May 31, 2024, but no longer expects to generate positive adjusted free cash flow for the full fiscal year 2024 due to delayed cash collection on asset sales. The company aims to become a top 12 U.S. beer and alcohol beverage company.

Management Comments

• Irwin D. Simon, Tilray Brands Chairman and Chief Executive Officer, stated that Tilray is well-positioned to navigate the current environment and benefit from future growth opportunities.
• Mr. Simon also stated that Tilray has become the most dynamic and diversified cannabis-lifestyle and consumer products company globally.
• Management highlighted several achievements during the third quarter, including revenue growth, increased adjusted gross profit, reduced convertible debt, and integration of acquired brands.

Industry Context

This announcement reflects Tilray's strategy to diversify its business beyond cannabis into the beverage-alcohol and wellness sectors. The company's acquisitions and expansion efforts are aimed at capturing a larger share of the consumer packaged goods market. The potential rescheduling of cannabis in the U.S. could provide further growth opportunities for Tilray.

Comparison to Industry Standards

• Tilray's 30% revenue growth is strong compared to some of its cannabis peers, but the company's adjusted EBITDA of $10.2 million is lower than some of the larger, more established players in the industry.
• The 165% growth in beverage-alcohol revenue is significant, placing Tilray as the 5th largest craft brewer in the U.S., but the decrease in gross margin in this segment due to acquisitions is a concern.
• Compared to other cannabis companies, Tilray's international cannabis growth of 44% is a positive sign of its global expansion strategy.
• The company's debt reduction efforts are a positive step towards improving its financial health, but the negative adjusted free cash flow guidance is a concern.
• Tilray's strategy of acquiring established brands in the beverage sector is similar to other companies looking to diversify their revenue streams, but the success of this strategy will depend on the company's ability to integrate these brands and improve their profitability.

Stakeholder Impact

• Shareholders may be encouraged by the revenue growth and debt reduction, but concerned about the lower EBITDA and negative free cash flow guidance.
• Employees may be impacted by the integration of acquired companies and cost reduction plans.
• Customers may benefit from the expanded product offerings and brand portfolio.
• Suppliers may see increased demand due to the company's growth.
• Creditors may be reassured by the debt reduction efforts, but concerned about the negative free cash flow.

Next Steps

• Tilray intends to continue to opportunistically repurchase additional notes to optimize its capital structure.
• The company will focus on integrating recently acquired craft beverage brands.
• Tilray will continue to pursue its three-pronged approach to become a top 12 U.S. beer and alcohol beverage company.
• The company will continue to focus on growing its leading market share in medical cannabis across Europe and other international markets.

Key Dates

Keywords

cannabis, beverage-alcohol, craft beer, revenue growth, EBITDA, market share, acquisitions, debt reduction, gross margin, financial results